A recent phase 2 clinical trial reveals that Ambroxol, a common cough medicine, shows promise in stabilizing psychiatric ...

They were designed to treat diabetes, then prescribed for weight loss, and now—as researchers are finding—they might hold the ...

In a small clinical trial in Canada, a medicine commonly found in European cough syrups has shown early signs it might do ...

A study reveals that a common genetic mutation doubles the risk of dementia in men, linking it to problems with iron ...

Ambroxol, long used for coughs in Europe, stabilized symptoms and brain-damage markers in Parkinson’s dementia patients over ...

Ambroxol, a cough medication, may help stabilize the neuropsychiatric symptoms of Parkinson's disease dementia, a new study ...

A safe and affordable treatment to slow the advancement of Parkinson's dementia has emerged – in the form of a commonly ...

The median time from Parkinson's diagnosis to dementia diagnosis in the Penn cohort was 19.4 years for patients younger than 56, 14.6 years for those ages 56 to 70, and 9.2 years for those older ...

Dutch researchers studied the risk of dementia, Parkinson's disease, and stroke through a large study of 12,000 people. Getty Images . Read more: Skinny fat body type linked to dementia Women were ...